Nathan Blessing is an Ophthalmology physician affiliated with University of Miami. OpenAlex indexes 29 publications with 210 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Glaukos CorporationProgram year20251 payment
- ABBVIE INC.Program year20241 payment
- Halozyme IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
74.2%Neuromuscular Blocker74.2%Onabotulinumtoxina100%Part B, office-administered≥13 patientsSensory organs
23.8%Aminoglycoside Antibacterial22.3%Neomycin-Polymyxin-Dexameth100%Part D≥272 patientsPolymyxin-class Antibacterial0.8%Polymyxin B Sul-Trimethoprim100%Part D<11 patients+ 1 more class in this area
Anti-infectives
2%Macrolide0.7%Erythromycin100%Part D≥11 patientsFirst-generation cephalosporins0.7%Cephalexin100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Orbital Exenteration Trends at a Single Institution From 2011 to 2024
Ophthalmic Plastic and Reconstructive Surgery
2025 - Efficacy of Topical Chemotherapy in Ocular Adnexal Sebaceous Carcinoma
Ophthalmic Plastic and Reconstructive Surgery
2025 - Periorbital Pyoderma Gangrenosum Associated With a Cocaine-Induced Midline Destructive Lesion: Case Report and Review of the Literature
Ophthalmic Plastic and Reconstructive Surgery
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Carlos Singer
University of Miami
Sebastian Koch, MD
University of Miami
Jay Spiegel, MD
University of Miami
Kara Cavuoto, MD
University of Miami
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”